Ask
Search
My library
ORKG

About
Statistics
Contact
Data Protection
Accessibility
Imprint
Changelog
Frontend: v1.32.0
Backend: v1.11.4

We use cookies to provide a better user experience.

Data Protection

<i>In vitro</i> susceptibility of 47 <i>Candida</i> spp. strains against 4 antifungal agents.

André Mario Doi (2187436)
Antonio Carlos Campos Pignatari (2187442)
Michael B. Edmond (330638)
Alexandre Rodrigues Marra (2187433)
Luis Fernando Aranha Camargo (430601)
Ricardo Andreotti Siqueira (2187430)
Vivian Pereira da Mota (2187439)
Arnaldo Lopes Colombo (652466)

Publication date

January 2016

DOI

10.1371/journal.pone.0146909.t003

Abstract

<p><i>In vitro</i> susceptibility of 47 <i>Candida</i> spp. strains against 4 antifungal agents.</p

Extracted data

Related items

In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus.

MANFREDI, Maddalena
POLONELLI, Luciano
CONTI, Stefania
VESCOVI, Paolo
McCullough M.J.
Al Karaawi Z.M.
Porter S.R.

January 2006

The most common antifungal drugs in current clinical use for the treatment of oral candidosis are po...

IN VITRO SUSCEPTIBILITY OF Candida Spp. ISOLATED FROM CLINICAL SPECIMENS AGAINST SOME ANTIFUNGAL AGENTS

Berrin ÖZÇELIK
Neriman BALABAN
Sebahat AKSARAY
Salih CESUR
Fatma KAYNAK
Altan ÇAYIRLI

April 2006

We evaluated the in vitro activity of ketoconazole (KET), fluconazole (FLU), itraconazole (ITRA), am...

Correlation between in vitro and in vivo activity of antifungal agents against yeasts

Bille, J.

January 1996

Antifungal susceptibility testing for yeasts ideally should allow to compare the activity of various...

<i>In vitro</i> susceptibility of <i>Candida</i> species to four antifungal agents.

Marcio Nucci (398804)
Flavio Queiroz-Telles (398805)
Tito Alvarado-Matute (398806)
Iris Nora Tiraboschi (398807)
Jorge Cortes (189679)
Jeannete Zurita (398808)
Manuel Guzman-Blanco (398809)
Maria Elena Santolaya (398810)
Luis Thompson (398811)
Jose Sifuentes-Osornio (5654464)
Juan I. Echevarria (398812)
Arnaldo L. Colombo (398813)

March 2013

<p>MIC = minimal inhibitory concentration; SDD = susceptible, dose-dependent; I = intermediate; NA =...

Correlation between in vitro and in vivo activity of antifungal agents against Candida species

Elias J. Anaissie
Nicholas C. Karyotakis
Ray Hachem
Maria C. Dignani
John H. Rex
Victor Paetznick

October 2016

The correlation between antifungal susceptibility testing and in vivo response to antifungal therapy...

In vitro susceptibility of oral Candida to seven antifungal agents

Kuriyama, Tomoari
Williams, David Wynne
Bagg, J.
Coulter, W. A.
Ready, D.
Lewis, Michael Alexander Oxenham

January 2005

The in vitro susceptibility of 618 Candida isolates to fluconazole, itraconazole, voriconazole, keto...

In vitro susceptibility of oral Candida to seven antifungal agents

Kuriyama, Tomoari
Williams, David Wynne
Bagg, J.
Coulter, W. A.
Ready, D.
Lewis, Michael Alexander Oxenham

January 2005

The in vitro susceptibility of 618 Candida isolates to fluconazole, itraconazole, voriconazole, keto...

In vitro susceptibility of oral Candida to seven antifungal agents

Kuriyama, Tomoari
Williams, David Wynne
Bagg, J.
Coulter, W. A.
Ready, D.
Lewis, Michael Alexander Oxenham

January 2005

The in vitro susceptibility of 618 Candida isolates to fluconazole, itraconazole, voriconazole, keto...

In vitro susceptibility testing of Candida species isolated from blood stream infections to five conventional antifungal drugs

Mahdis Hosein Khezri
Farideh Zaini
Parivash Kordbache
Mohammad Ghahri
Pegah Ardi
Zahra Rafat

October 2019

Candida is an opportunistic fungal pathogen which can cause fatal bloodstream infections (BSIs) in i...

Identification and antifungal susceptibility of candida isolates from various clinical specimens in doctor Behçet uz hospital

Tulumoglu Ş.
Kariptaş E.
Erdem B.

January 2009

The purpose of this study was to identify and determine antifungal susceptibility patterns of 101 ye...

Antifungal susceptibility profiles of 1698 yeast reference strains revealing potential emerging human pathogens.

Marie Desnos-Ollivier
Vincent Robert
Dorothée Raoux-Barbot
Marizeth Groenewald
Françoise Dromer

New molecular identification techniques and the increased number of patients with various immune def...

Antifungal Susceptibility Profiles of 1698 Yeast Reference Strains Revealing Potential Emerging Human Pathogens

Desnos-Ollivier, Marie
Robert, Vincent
Raoux-Barbot, Dorothée
Groenewald, Marizeth
Dromer, Françoise

March 2012

International audienceNew molecular identification techniques and the increased number of patients w...

Antifungal Susceptibility Profiles of 1698 Yeast Reference Strains Revealing Potential Emerging Human Pathogens

Desnos-Ollivier, Marie
Robert, Vincent
Raoux-Barbot, Dorothée
Groenewald, Marizeth
Dromer, Françoise

March 2012

International audienceNew molecular identification techniques and the increased number of patients w...

ANTIFUNGAL SUSCEPTIBILITY PATTERNS AND VIRULENCE FACTORS OF CLINICAL CANDIDA SPP. ISOLATES

Burduniuc Olga

November 2021

Objective. The global emergence of antifungal resistance among Candida spp. is a growing threat to p...

ANTIFUNGAL SUSCEPTIBILITY PATTERNS AND VIRULENCE FACTORS OF CLINICAL CANDIDA SPP. ISOLATES

Olga Burduniuc

November 2021

Objective. The global emergence of antifungal resistance among Candida spp. is a growing threat to p...

In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus.

MANFREDI, Maddalena
POLONELLI, Luciano
CONTI, Stefania
VESCOVI, Paolo
McCullough M.J.
Al Karaawi Z.M.
Porter S.R.

January 2006

The most common antifungal drugs in current clinical use for the treatment of oral candidosis are po...

IN VITRO SUSCEPTIBILITY OF Candida Spp. ISOLATED FROM CLINICAL SPECIMENS AGAINST SOME ANTIFUNGAL AGENTS

Berrin ÖZÇELIK
Neriman BALABAN
Sebahat AKSARAY
Salih CESUR
Fatma KAYNAK
Altan ÇAYIRLI

April 2006

We evaluated the in vitro activity of ketoconazole (KET), fluconazole (FLU), itraconazole (ITRA), am...

Correlation between in vitro and in vivo activity of antifungal agents against yeasts

Bille, J.

January 1996

Antifungal susceptibility testing for yeasts ideally should allow to compare the activity of various...

<i>In vitro</i> susceptibility of <i>Candida</i> species to four antifungal agents.

Marcio Nucci (398804)
Flavio Queiroz-Telles (398805)
Tito Alvarado-Matute (398806)
Iris Nora Tiraboschi (398807)
Jorge Cortes (189679)
Jeannete Zurita (398808)
Manuel Guzman-Blanco (398809)
Maria Elena Santolaya (398810)
Luis Thompson (398811)
Jose Sifuentes-Osornio (5654464)
Juan I. Echevarria (398812)
Arnaldo L. Colombo (398813)

March 2013

<p>MIC = minimal inhibitory concentration; SDD = susceptible, dose-dependent; I = intermediate; NA =...

Correlation between in vitro and in vivo activity of antifungal agents against Candida species

Elias J. Anaissie
Nicholas C. Karyotakis
Ray Hachem
Maria C. Dignani
John H. Rex
Victor Paetznick

October 2016

The correlation between antifungal susceptibility testing and in vivo response to antifungal therapy...

In vitro susceptibility of oral Candida to seven antifungal agents

Kuriyama, Tomoari
Williams, David Wynne
Bagg, J.
Coulter, W. A.
Ready, D.
Lewis, Michael Alexander Oxenham

January 2005

The in vitro susceptibility of 618 Candida isolates to fluconazole, itraconazole, voriconazole, keto...

In vitro susceptibility of oral Candida to seven antifungal agents

Kuriyama, Tomoari
Williams, David Wynne
Bagg, J.
Coulter, W. A.
Ready, D.
Lewis, Michael Alexander Oxenham

January 2005

The in vitro susceptibility of 618 Candida isolates to fluconazole, itraconazole, voriconazole, keto...

In vitro susceptibility of oral Candida to seven antifungal agents

Kuriyama, Tomoari
Williams, David Wynne
Bagg, J.
Coulter, W. A.
Ready, D.
Lewis, Michael Alexander Oxenham

January 2005

The in vitro susceptibility of 618 Candida isolates to fluconazole, itraconazole, voriconazole, keto...

In vitro susceptibility testing of Candida species isolated from blood stream infections to five conventional antifungal drugs

Mahdis Hosein Khezri
Farideh Zaini
Parivash Kordbache
Mohammad Ghahri
Pegah Ardi
Zahra Rafat

October 2019

Candida is an opportunistic fungal pathogen which can cause fatal bloodstream infections (BSIs) in i...

Identification and antifungal susceptibility of candida isolates from various clinical specimens in doctor Behçet uz hospital

Tulumoglu Ş.
Kariptaş E.
Erdem B.

January 2009

The purpose of this study was to identify and determine antifungal susceptibility patterns of 101 ye...

Antifungal susceptibility profiles of 1698 yeast reference strains revealing potential emerging human pathogens.

Marie Desnos-Ollivier
Vincent Robert
Dorothée Raoux-Barbot
Marizeth Groenewald
Françoise Dromer

New molecular identification techniques and the increased number of patients with various immune def...

Antifungal Susceptibility Profiles of 1698 Yeast Reference Strains Revealing Potential Emerging Human Pathogens

Desnos-Ollivier, Marie
Robert, Vincent
Raoux-Barbot, Dorothée
Groenewald, Marizeth
Dromer, Françoise

March 2012

International audienceNew molecular identification techniques and the increased number of patients w...

Antifungal Susceptibility Profiles of 1698 Yeast Reference Strains Revealing Potential Emerging Human Pathogens

Desnos-Ollivier, Marie
Robert, Vincent
Raoux-Barbot, Dorothée
Groenewald, Marizeth
Dromer, Françoise

March 2012

International audienceNew molecular identification techniques and the increased number of patients w...

ANTIFUNGAL SUSCEPTIBILITY PATTERNS AND VIRULENCE FACTORS OF CLINICAL CANDIDA SPP. ISOLATES

Burduniuc Olga

November 2021

Objective. The global emergence of antifungal resistance among Candida spp. is a growing threat to p...

ANTIFUNGAL SUSCEPTIBILITY PATTERNS AND VIRULENCE FACTORS OF CLINICAL CANDIDA SPP. ISOLATES

Olga Burduniuc

November 2021

Objective. The global emergence of antifungal resistance among Candida spp. is a growing threat to p...

In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus.

MANFREDI, Maddalena
POLONELLI, Luciano
CONTI, Stefania
VESCOVI, Paolo
McCullough M.J.
Al Karaawi Z.M.
Porter S.R.

January 2006

The most common antifungal drugs in current clinical use for the treatment of oral candidosis are po...

IN VITRO SUSCEPTIBILITY OF Candida Spp. ISOLATED FROM CLINICAL SPECIMENS AGAINST SOME ANTIFUNGAL AGENTS

Berrin ÖZÇELIK
Neriman BALABAN
Sebahat AKSARAY
Salih CESUR
Fatma KAYNAK
Altan ÇAYIRLI

April 2006

We evaluated the in vitro activity of ketoconazole (KET), fluconazole (FLU), itraconazole (ITRA), am...

Correlation between in vitro and in vivo activity of antifungal agents against yeasts

Bille, J.

January 1996

Antifungal susceptibility testing for yeasts ideally should allow to compare the activity of various...